Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong JW Medical Products is a leading Chinese medical device company specializing in the development, manufacturing, and commercialization of interventional cardiology products. Founded in 2003, the company is best known for its Excel biodegradable polymer drug-eluting stent, which was the first of its kind to be launched in the Chinese market. It operates as a key subsidiary of Biosensors International, which is owned by Blue Sail Medical. The company's extensive portfolio includes various coronary stents, balloon catheters, and interventional accessories used in percutaneous coronary intervention procedures. With large-scale manufacturing facilities in Yantai, Shandong, JW Medical remains a dominant player in the cardiovascular device sector in the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong JW Medical Products.